🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Okay, updated short course table with primaquin for vivax malaria included. Getting awfully crowded!

SARS-CoV-2 antibodies in baby born to #COVID19+ mom may suggest in-utero transmission. Thanks Emory School of Medicine MS3s Kerri Andre & Elizabeth Soffer (creators), @cg_coleman (editor), & Emory Peds ID fellow Maddie Goldstein (peer-reviewer)! #EducationInTheTimeOfCOVID #COVID19FOAM

As it's #heartfailureawarenessweek here's a link to the CardioNerds podcasts on the subject of HF. All of them are great listens and would probably last as long as your commute to work. Brad Hochberg BSH Nurse Forum Team Cardiology Q.A cardionerds.com/episodes/heart…

Announcing the 4th Annual #WomeninCardiology Career Development Event on October 7th. This year, we are excited to bring to you an esteemed guest speaker Dr. Dipti Itchhaporia, M.D., MACC , FAHA, FESC, President of American College of Cardiology. Click the link below to register. tinyurl.com/ydmt8sth

Since the beginning I've said the mRNA vaccines = 3 dose vaccines. Reason: We spaced first two doses close together to rapidly immunize vulnerable populations, but that had the downside of acting as a primary immunization, necessitating a third dose. The good news...

2022 ACC/AHA/HFSA HF guidelines are out. I would like to thank the writing group members and the the staff for their tireless efforts. We are excited and encourage all clinicians to check it it out . New Recommendations & helpful figures jacc.org/doi/10.1016/j.…

UCSF Cardiac Hospitalists at #ACC22! 🫀 I’ve had an incredible time so far learning about late breaking clinical trials, new ACC guidelines, catching up w old friends, making new ones, and much more.

New Besties! #ACC22 ⁦American College of Cardiology⁩ Harmanjot Kaur Gill ⁦Nisha Donthi⁩ ⁦Katharine Yang⁩

Honored to have met ACC President Dr. Dipti Itchhaporia, M.D., MACC , FAHA, FESC who inspires the next generation of female cardiologists like us! Nisha Donthi Harmanjot Kaur Gill American College of Cardiology #ACC22 #ACCWIC

Thankful for the great discussions ranging from being a woman cardiologist to women’s CV health with Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦, especially in regards to more awareness required for CVD in the South Asian community!

What a beautiful crew of #wic lead by the no other Erin D. Michos, M.D.. Thank you for being such an incredible mentor, leader and advocate in #cvprevention #cardioOB Alaa Diab, MD MPH Jessie Holtzman Katharine Yang

Reunited 🙏 From medical students 👩🏻‍⚕️ to cardiology fellows 🫀!

#AHA22 LBCTs one liners: 1. TRANSFORM-HF: Torsemide was not superior to furosemide in improving survival among patients treated for decompensated HF. 2. DCP: No differences in cardiovascular outcomes between chlorthalidone and HCTZ among elderly veterans with HTN.

🔥Highlights from the Late breaking SMART trial studying Self-Expanding vs. Balloon-Expandable TAVR in patients with small aortic annuli - that enrolled 75% women! 🔥 #ACC24 Cardiac Trials

#ACC24 Late Breaking Trial: REDUCE-AMI - Approx 5000 patients who were post MI and had LVEF >= 50% were randomized to beta blocker vs. no blocker - Median follow-up of 3.5 years - No difference in primary endpoint of all-cause death or MI, or secondary endpoints! Cardiac Trials

Wonderful to see Dr. Ajay Vaidya at #ACC24, my heart failure cardiology attending at LAC+USC Cardiovascular Medicine Fellowship and a great clinician-educator, who inspired me to pursue cardiology when I was still an undifferentiated LAC + USC Residents IM resident 🫀🫀🫀 #gratitude #ACCFIT

#ACC24 LBT: DanGer Shock - 355 Danish/German/UK (79% male) patients post-AMI in cardiogenic shock were randomized to ImpellaCP+standard care vs. standard care only - Significant ⬇️ 1° endpt of death from any cause at 180d - But ⬆️ risk of bldg, RRT, sepsis Cardiac Trials

Dr. Ileana Pina shares tips for success to enroll more women in clinical trials: 1) Women in clinical trial leadership 2) Convenience of research measures and enrollment— enroll in clinic and in presence of patient’s families 3) budget for transportation/partner with rideshare

Members from #ACCWIC and #ACCCVManage Member Sections developed a toolkit focusing on how to start a heart center for women & how to manage the care of women w/ or at risk for #CVD. Learn more and access the toolkit here: bit.ly/41LzoHZ

Here’s my guide to navigate the #ACC25 trials, coming this weekend and featured in many journals with a (very) high impact factor. 1. WARRIOR = Intensive medical therapy in women with ANOCA/INOCA 2. STRIDE = Semaglutide in type 2 diabetes and peripheral artery disease 3. API-CAT